Biotech

All Articles

FDA locations Kezar lupus trial in grip following 4 individual deaths

.The FDA has put Kezar Life Sciences' lupus trial on grip after the biotech flagged 4 fatalities in ...

Phase 3 Academic Stone trial reaches SMA target, sending stockpile 200%

.A period 3 test of Historian Stone's vertebral muscle degeneration (SMA) applicant has reached its ...

CAMP 4 is most recent to eye IPO, while Upstream describe $182M plan

.RNA biotech CAMP4 Therapies has defined prepare for a $67 million IPO, with inflammation-focused Up...

Galecto buys leukemia drug, drops bone cancer cells asset in pivot

.A year after the breakdown of an idiopathic lung fibrosis candidate delivered Galecto on a seek red...

Judo tosses down $100M to knock senseless kidney illness

.Taking the mat is Judo Biography, a promising biotech armed along with $100 million to cultivate ol...

AstraZeneca pays for CSPC $100M for preclinical heart problem drug

.AstraZeneca has actually settled CSPC Pharmaceutical Team $one hundred million for a preclinical ca...

Zephyrm finds Hong Kong IPO to cash period 3 tissue treatment trials

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock market, submitting (PDF) for an I...

Frazier Lifestyle Sciences gathers $630M for tiny, mid-cap biotechs

.Frazier Daily life Sciences has sourced a better $630 million for its fund concentrated on small as...

GigaGen gets up to $135M BARDA money to hammer botox

.Antibody enthusiast GigaGen, a subsidiary of Spanish biopharma Grifols, is actually increase its ow...

GPCR firm Septerna apply for IPO on toughness of preclinical information

.Septerna is about to find out exactly how a biotech without "any kind of meaningful clinical record...